Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

REDX.L (REDX) Regulatory News

Date Source Headline
8th Aug 2016 10:55 am RNS Hardman Research: Moving to clinic, rising value
17th Jun 2016 12:15 pm RNS Redx to present at ASM Microbe 2016 Conference
24th May 2016 7:00 am RNS Proof of concept with key oncology lead
24th May 2016 7:00 am RNS Half-year Report
19th May 2016 7:00 am RNS Re Review on Antimicrobial Resistance
9th May 2016 7:00 am RNS Board Appointment
26th Apr 2016 3:37 pm RNS Holding(s) in Company
19th Apr 2016 4:52 pm RNS Holding(s) in Company
18th Apr 2016 7:00 am RNS Holding(s) in Company
15th Apr 2016 5:10 pm RNS Holding(s) in Company
13th Apr 2016 12:06 pm RNS Result of General Meeting and Issue of Equity
4th Apr 2016 2:58 pm RNS Grant of Options
4th Apr 2016 12:59 pm RNS Result of General Meeting
4th Apr 2016 7:00 am RNS Issue of Equity
29th Mar 2016 7:00 am RNS Director/PDMR Shareholding
24th Mar 2016 1:55 pm RNS Placing to Raise £10 Million
8th Mar 2016 7:00 am RNS Change of Adviser
24th Feb 2016 12:39 pm RNS Result of AGM
24th Feb 2016 7:00 am RNS AGM Statement
22nd Jan 2016 9:09 am RNS Hardman & Co Research Report: Pipeline progress
22nd Jan 2016 7:30 am RNS Hardman & Co Research Report: Pipeline progress
20th Jan 2016 7:00 am RNS Final Results
6th Jan 2016 7:00 am RNS Notice of Results
4th Jan 2016 7:00 am RNS Appointment of Non-Executive Director
3rd Dec 2015 7:00 am RNS Fourth drug development candidate
10th Nov 2015 7:00 am RNS Re BioInfect Conference 2015
5th Nov 2015 7:00 am RNS Senior management appointments
23rd Oct 2015 2:57 pm RNS Re Review on Antimicrobial Resistance
1st Oct 2015 7:00 am RNS Trading Update
3rd Sep 2015 7:00 am RNS Cancer Research Collaboration with Redx Pharma
3rd Sep 2015 7:00 am RNS Cancer Research Collaboration
22nd Jun 2015 7:00 am RNS Half Yearly Report
19th Jun 2015 5:14 pm RNS Holding(s) in Company
4th Jun 2015 9:45 am RNS Holding(s) in Company
2nd Jun 2015 7:00 am RNS Discovery of breakthrough MRSA compound
26th May 2015 7:01 am RNS Second drug development candidate identified
14th May 2015 7:00 am RNS Re Review on Antimicrobial Resistance
14th May 2015 7:00 am RNS Launch of third subsidiary, Redx Immunology
11th May 2015 7:00 am RNS Pre-Clinical Proof of Concept with Oncology Lead
31st Mar 2015 5:13 pm RNS Holding(s) in Company
FTSE 100 Latest
Value8,809.74
Change53.53